IL114144A - Pharmaceutical compositions containing a hydrophobic substance and an effervescent system and their preparation - Google Patents

Pharmaceutical compositions containing a hydrophobic substance and an effervescent system and their preparation

Info

Publication number
IL114144A
IL114144A IL11414495A IL11414495A IL114144A IL 114144 A IL114144 A IL 114144A IL 11414495 A IL11414495 A IL 11414495A IL 11414495 A IL11414495 A IL 11414495A IL 114144 A IL114144 A IL 114144A
Authority
IL
Israel
Prior art keywords
pct
preparation
effervescent system
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL11414495A
Other versions
IL114144A0 (en
Original Assignee
Gergely Gerhard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gergely Gerhard filed Critical Gergely Gerhard
Publication of IL114144A0 publication Critical patent/IL114144A0/en
Publication of IL114144A publication Critical patent/IL114144A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PCT No. PCT/EP95/01904 Sec. 371 Date Dec. 17, 1996 Sec. 102(e) Date Dec. 17, 1996 PCT Filed May 19, 1995 PCT Pub. No. WO95/34284 PCT Pub. Date Dec. 21, 1995A pharmaceutical formulation includes a hydrophobic active substance, an effervescent system, and at least two surfactants. Each of the surfactants is selected from a different group selected from the following three groups: phospholipids, polysorbates, and esterified sugars. The formulations provide improved dispersion and bioavailability of hydrophobic active substances.
IL11414495A 1994-06-15 1995-06-14 Pharmaceutical compositions containing a hydrophobic substance and an effervescent system and their preparation IL114144A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH01890/94A CH686865A5 (en) 1994-06-15 1994-06-15 Pharmaceutical preparation containing a hydrophobic active ingredient and an effervescent system, and processes for producing the preparation.

Publications (2)

Publication Number Publication Date
IL114144A0 IL114144A0 (en) 1995-10-31
IL114144A true IL114144A (en) 1999-07-14

Family

ID=4221002

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11414495A IL114144A (en) 1994-06-15 1995-06-14 Pharmaceutical compositions containing a hydrophobic substance and an effervescent system and their preparation

Country Status (26)

Country Link
US (1) US5834019A (en)
EP (1) EP0768868B1 (en)
JP (1) JPH10501535A (en)
KR (1) KR100367302B1 (en)
CN (1) CN1149071C (en)
AT (1) ATE204744T1 (en)
AU (1) AU684966B2 (en)
BR (1) BR9508002A (en)
CA (1) CA2191302C (en)
CH (1) CH686865A5 (en)
CO (1) CO4410175A1 (en)
CZ (1) CZ287807B6 (en)
DE (1) DE59509566D1 (en)
ES (1) ES2161901T3 (en)
HU (1) HU221680B1 (en)
IL (1) IL114144A (en)
MX (1) MX9606391A (en)
MY (1) MY113718A (en)
NO (1) NO314016B1 (en)
NZ (1) NZ288208A (en)
PE (1) PE42295A1 (en)
PL (1) PL180135B1 (en)
SK (1) SK281262B6 (en)
TW (1) TW457097B (en)
WO (1) WO1995034284A1 (en)
ZA (1) ZA954932B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0803251B1 (en) * 1996-04-23 2002-07-17 Janssen Pharmaceutica N.V. Immediate release pH-independent solid dosage form of cisapride
DE69713948D1 (en) * 1996-04-23 2002-08-22 Janssen Pharmaceutica Nv Rapidly releasing pH-independent solid dosage forms containing cisapride
CA2292628A1 (en) * 1997-06-11 1998-12-17 Janssen Pharmaceutica, N.V. Immediate release ph-independent solid dosage form of (+)- or (-)-cisapride
US6589555B2 (en) 1999-12-29 2003-07-08 Mahendra Pandya Effervescent vitaceutical compositions and related methods
AU2002220248A1 (en) * 2000-11-06 2002-05-15 Andrx Pharmaceuticals, Inc. Once a day antihistamine and decongestant formulation
US20030157170A1 (en) * 2001-03-13 2003-08-21 Richard Liggins Micellar drug delivery vehicles and precursors thereto and uses thereof
WO2002072150A2 (en) 2001-03-13 2002-09-19 Angiotech Pharmaceuticals Inc. Micellar drug delivery vehicles and uses thereof
ATE363898T1 (en) 2001-04-20 2007-06-15 Univ British Columbia MICELLAR DRUG DELIVERY SYSTEM FOR HYDROPHOBIC DRUGS
PL206018B1 (en) * 2001-10-19 2010-06-30 Isotechnika Inc Novel cyclosporin analog microemulsion preconcentrates
US8092831B2 (en) * 2002-11-08 2012-01-10 Andrx Pharmaceuticals, Llc Antihistamine and decongestant system
US20050069590A1 (en) * 2003-09-30 2005-03-31 Buehler Gail K. Stable suspensions for medicinal dosages
CN100381123C (en) * 2005-01-12 2008-04-16 南京亿华药业有限公司 Granules of clarityne and their production
CN101897732B (en) * 2009-05-27 2013-01-30 北京因科瑞斯医药科技有限公司 Chinese medicinal effervescence medicament and preparation method thereof
CN106236713B (en) * 2016-08-30 2018-11-09 林州中农颖泰生物肽有限公司 Seven clear Toxin-Vanquishing effervescence granulars of one kind and preparation method thereof
CN107296800A (en) * 2017-06-01 2017-10-27 江苏黄河药业股份有限公司 A kind of Loratadine effervescent tablet and preparation method thereof
CN112741841A (en) * 2019-10-29 2021-05-04 湖北真奥医药研究院有限公司 Three-dimensional calcium self-emulsifying effervescent composition and preparation method of preparation thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3584522D1 (en) * 1984-12-14 1991-11-28 Gergely Gerhard PARTICLES FROM A HYDROPHOBIC OR HARDLY SOLUBLE SUBSTANCE AND METHOD FOR THEIR HYDROPHILIZATION.
GB8528195D0 (en) * 1985-11-15 1985-12-18 Boots Co Plc Therapeutic compositions
GB9224021D0 (en) * 1992-11-16 1993-01-06 Boots Co Plc Effervescent compositions
US5646131A (en) * 1994-02-22 1997-07-08 The Arab Company For Drug Industries And Medical Applicances (Acdima) Method for solubilizing drugs using cyclodextrins and carboxylic acids
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs

Also Published As

Publication number Publication date
ZA954932B (en) 1996-02-07
AU2749795A (en) 1996-01-05
CN1151693A (en) 1997-06-11
CN1149071C (en) 2004-05-12
ATE204744T1 (en) 2001-09-15
PL317856A1 (en) 1997-04-28
CZ367296A3 (en) 1997-04-16
NO965244L (en) 1997-02-13
HUT75674A (en) 1997-05-28
HU221680B1 (en) 2002-12-28
EP0768868B1 (en) 2001-08-29
HU9603452D0 (en) 1997-02-28
CO4410175A1 (en) 1997-01-09
KR970703131A (en) 1997-07-03
IL114144A0 (en) 1995-10-31
NZ288208A (en) 1998-08-26
MX9606391A (en) 1997-07-31
BR9508002A (en) 2000-05-30
ES2161901T3 (en) 2001-12-16
CH686865A5 (en) 1996-07-31
SK159396A3 (en) 1997-08-06
EP0768868A1 (en) 1997-04-23
AU684966B2 (en) 1998-01-08
PE42295A1 (en) 1995-12-28
KR100367302B1 (en) 2003-04-16
CA2191302C (en) 2010-08-10
NO314016B1 (en) 2003-01-20
PL180135B1 (en) 2000-12-29
CA2191302A1 (en) 1995-12-21
SK281262B6 (en) 2001-01-18
WO1995034284A1 (en) 1995-12-21
TW457097B (en) 2001-10-01
DE59509566D1 (en) 2001-10-04
CZ287807B6 (en) 2001-02-14
NO965244D0 (en) 1996-12-09
JPH10501535A (en) 1998-02-10
US5834019A (en) 1998-11-10
MY113718A (en) 2002-05-31

Similar Documents

Publication Publication Date Title
IL114144A0 (en) Pharmaceutical compositions containing a hydrophobic substance and an effervescent system and their preparation
ATE554750T1 (en) PREPARATIONS CONTAINING HYDROPHOBIC PHARMACEUTICAL ACTIVE INGREDIENTS
AU5651696A (en) Substituted 1-phenyl-3-pyrazolecarboxamides active on nurotensin receptors, their preparation and pharmaceutical compositions containing them
CA2133175A1 (en) Rapamycin formulations for oral administration
GEP20002211B (en) Taxoids, Preparation Thereof, Pharmaceutical Compositions Containing Same
CA2180816A1 (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
CA2193337A1 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
GR3025321T3 (en) Hydrophilic groups containing poly(vinylamine) derivatives, process for their manufacture and use thereof as pharmaceutical compounds, substrates for active substances and foodstuff ingredients
EP0727217A3 (en) Pharmaceutical composition containing god-type ellagitannin as active ingredient
PL317225A1 (en) Drugs
CA2033725A1 (en) Pharmaceutical and cosmetic compositions containing a salt of cholanic acid
IL122249A0 (en) Fluorocarbon pharmaceutical formulations and their preparation
IL136285A0 (en) Pharmaceutical compositions containing an acid-labile active component
AU1180997A (en) Novel taxoids, their preparation and pharmaceutical compositions containing them
AU8096591A (en) Composition for solid pharmaceutical preparations containing active vitamins d3 and process for preparation thereof
HUP9900365A2 (en) N-aryl-1,2,4-triazolin-5-on derivatives, preparation and use thereof, insecticide, arachnicide and nematocide compositions containing these compounds as active ingredients
BR9404225A (en) Formulation of active substance, application, compositions, drugs and process for the preparation of formulations
MY115016A (en) Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation
RU94040150A (en) Stable lyophilized thiotepa composition and method of its preparing
AU3777197A (en) Cyclosporin formulation
SE8302580D0 (en) SUBSTITUTED IMINO DERIVATIVES OF DIHYDROBENSOPYRANE AND DIHYDROBENZOPYRANE AND PROCEDURE FOR THEIR PREPARATION
GEP20022751B (en) Aqueous Pharmaceutical Composition Comprising an Active Ingredient Which Is Highly Insoluble in Water
HRP940315B1 (en) Process for the preparation of pharmaceutical compositions containinbg active ingredient
CA2169696A1 (en) Substituted benzenesulfonylureas and -thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them
ID17995A (en) STABLE MIXES OF ACTIVE INGREDIENTS THAT ARE NOT SUITABLE FOR PLANT PROTECTION

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees